NCT03769766View on ClinicalTrials.gov

Trial of Curcumin to Prevent Progression of Low-risk Prostate Cancer Under Active Surveillance

PHASE3RecruitingINTERVENTIONAL
Enrollment

291

Participants

Timeline

Start Date

March 11, 2019

Primary Completion Date

November 30, 2029

Study Completion Date

November 30, 2030

Conditions
Prostate Cancer
Interventions
DRUG

Curcumin

Take medication one 500 mg pill of BCM-95 taken twice daily

DRUG

Placebo

Take medication one 500mg pill twice daily

Trial Locations (1)

75390

RECRUITING

UT Southwestern Medical Center, Dallas

All Listed Sponsors
lead

University of Texas Southwestern Medical Center

OTHER